Yousif Capital Management, LLC Horizon Therapeutics Public LTD CO Transaction History

Yousif Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	BUY	$98.98 - $115.74 $15,341 - $17,939	155 Added 5.97%	2,752 $318,000
Q2 2023 Aug 02, 2023	SELL	$96.34 - $112.38 $9,634 - $11,238	-100 Reduced 3.71%	2,597 $267,000
Q1 2023 May 02, 2023	BUY	$107.32 - $113.5 $4,829 - $5,107	45 Added 1.7%	2,697 $294,000
Q4 2022 Jan 09, 2023	BUY	$62.39 - $113.8 $165,458 - $301,797	2,652 New	2,652 $0
Q2 2022 Aug 01, 2022	SELL	$79.4 - $116.36 $66,696 - $97,742	-840 Reduced 24.79%	2,549 $203,000

Q1 2022 May 12, 2022	BUY	$86.42 - $109.81 $9,074 - $11,530	105 Added 3.2%	3,389 $357,000
Q4 2021 Jan 31, 2022	BUY	$98.56 - $119.91 $323,671 - $393,784	3,284 New	3,284 $354,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Yousif Capital Management, LLC with notifications on news.